Identification and characterization of Src SH3 ligands from phage-displayed random peptide libraries. by Sparks, Andrew B et al.
Communication Val. 269, No. 39,  Issue of September 30, pp. 23853-23856, 1994 0 1994 by The American Society for Biochemistry and Molecular Biology, Inc. 
Printed in U.S.A. 
THE JOURNAL OF BIOLOGICAL CHEMISTRY 
Identification  and 
Characterization of Src SH3 
Ligands from Phage-displayed 
Random Peptide  Libraries* 
(Received  for publication, July 27, 1994) 
Andrew B. Sparks$$,  Lawrence A. Quilliamll, 
Judith M. Thorn\(**,  Channing J. Derm $$, and 
Brian K. Kay$/($$ $§ 
From the *Curriculum in  Genetics and Molecular 
Biology, the Wepartment of Pharmacology,  the 
(Department of Biology, and the  SfLineberger 
Comprehensive  Cancer Center, University of North 
Carolina, Chapel Hill, North Carolina 27599 
We have used the Src homology 3 (SH3) domain to 
screen  two  phage-displayed  random  peptide  libraries, 
each  containing 2 x lo8 unique  members,  and  have  iden- 
tified  a  series of high  affinity  peptide  ligands. The  pep- 
tides  possess  similar  proline-rich  regions,  which  yield  a 
consensus Src  SH3-binding  motif  of  RPLPPLP. We have 
confirmed this motif by screening a phage-displayed 
peptide  library  biased  for SH3 ligands  and  identifying 
the same consensus sequence. Binding studies using 
synthetic  peptides  suggest  that  the RPLPPLP  motif is 
important  for  SH3  binding  and  confers  specificity  for 
the  Src  SI33  domain,  and  that  residues  which flank the 
motif  may also contribute  to  binding.  Peptides  that  con- 
tain  the RPLPPLP motif compete Src, but not Ab1 or 
phospholipase Cy,  SH3 interactions with SH3-binding 
proteins  from cell  lysates (IC5,, = 1-5 p). Furthermore, 
RPLPPLP-related  peptides  are  able  to  accelerate 
progesterone-induced  maturation of Xenopus Zaeuis 
oocytes. A similar acceleration has been observed in 
oocytes  treated  with  activated,  but  not  normal, Xenopus 
Src,  suggesting  the  possibility  that  the  peptides  are  able 
to  antagonize  the  negative  regulation  of  Src  activity  by 
Src  SH3 in uiuo. 
Src represents a family of at least  nine non-receptor protein- 
tyrosine  kinases;  members of this family share  an overall struc- 
tural organization comprising a series of catalytic and non- 
catalytic  domains (1). The carboxyl-terminal half of Src 
contains the protein-tyrosine kinase catalytic domain and a 
negative  regulatory  tyrosine (Tyr-527), whose phosphorylation 
results in the  inhibition of kinase activity  (2). The  amino-ter- 
minal  half of Src  contains two highly  conserved  non-catalytic 
regions termed Src homology (SH)' domains 2 and 3. SH2  and 
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SH3  domains  are composed of approximately 100 and 60 amino 
acids, respectively, are found in a variety of proteins with im- 
portant roles in signal  transduction,  and  have  been shown to 
mediate critical protein-protein interactions in a number of 
signaling pathways (3). SH2 domains bind phosphotyrosine 
(Tyr(P)); residues that surround  the Tyr(P) moiety determine 
SH2 specificity (4). SH3  domains recognize short proline-rich 
stretches of amino acids, although  the  basis for SH3 specificity 
remains  unclear (5). 
Many  mutations  that  result  in  increased Src protein-tyrosine 
kinase  and  transforming activity map to  the Src SH2  and  SH3 
domains (6-9), suggesting a negative  regulatory role for these 
domains. There  is evidence that both  domains  are involved in 
maintaining Tyr(P)-527-mediated inhibition of Src kinase ac- 
tivity (9-11). Whereas  the discovery that  SH2  domains  bind 
Tyr(P)-containing sequences has established an explanation for 
the role of the  SH2  domain  in Tyr(Pl-527-mediated inhibition of 
Src  activity (12), the role of the  SH3  domain  in  Src  regulation 
remains unclear.  Identification of Src  SH3  ligands  may provide 
insight  into  the role of the  SH3  domain  in  regulating  Src  and 
may  lead  to  the discovery of SH3-binding proteins critical for 
Src function and  transforming activity. 
Efforts to identify natural  ligands for different  SH3  domains 
have led to  the  characterization of a number of SH3-binding 
proteins, including the Ab1 SH3-binding proteins 3BP1 and 
3BP2 (13); the  Ras GTP-exchange factor SOS, which interacts 
with Grb2  (14, 15); p85  phosphatidylinositol 3'-kinase, which 
binds  Src,  Fyn,  and Lck SH3 (16, 30); dynamin, which binds 
SH3  domains from  Grb2, Src, Fyn, Fgr, and phospholipase C y  
(17); and  the  Src SH3-binding protein AFAP-110 (18). These 
proteins possess short proline-rich segments, some of which 
have  been directly implicated  in  SH3 binding.  Although  a num- 
ber of SH3  ligand  consensus motifs have  been proposed (13,171, 
factors  that govern the affinity and specificity of SH3 interac- 
tions  remain poorly defined. Attempts  to define SH3-binding 
consensus motifs and  to  elucidate  rules for ligand specificity 
have  been complicated by the  small  number of SH3 ligands 
characterized to date, the often low degree of similarity be- 
tween  ligands for the  same  SH3  domain,  and  the presence of 
multiple  overlapping  putative SH3-binding  regions within  the 
same  protein. 
Screening complex random  peptide  libraries  has proved to  be 
a powerful strategy for identifying  peptide  ligands for a variety 
of target molecules. Such  libraries  have been  used  to  identify 
peptide epitopes for monoclonal (19) and polyclonal (20)  anti- 
bodies, as well as  ligands for a variety of proteins, including 
streptavidin (21, 221, calmodulin' (241, and the endoplasmic 
reticulum  protein  BiP (23). 
To expand upon the  limited  repertoire of known SH3  ligands 
and  to  gain a more sophisticated  understanding of the role of 
the  SH3  domain in Src function, we have  used  the  Src  SH3 
domain to  isolate a series of peptide  ligands from  phage-dis- 
played random  peptide  libraries.  The  peptides possess similar 
proline-rich  regions,  which yield a consensus  equence of 
RPLPPLP. Binding studies using synthetic peptides suggest 
rosine; GST, glutathione S-transferase; PBS, phosphate-buffered sa- 
line; ELISA,  enzyme-linked  immunosorbent assay; RIPA,  radioimmune 
precipitation  buffer. 
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that  the  RPLPPLP motif is important for SH3 binding and 
confers specificity for the  Src SH3 domain, and  that residues 
which flank  the motif may also contribute  to binding. Further- 
more, RPLPPLP-related peptides act as potent and specific 
antagonists of Src  SH3  interactions  with SH3-binding proteins 
from cell lysates  and  accelerate progesterone-induced matura- 
tion of Xenopus laevis oocytes. 
EXPERIMENTAL PROCEDURES 
Preparation of GSTSH3  Fusion Proteins-PCR fragments encoding 
full-length  Grb2 or c-Src SH3 (amino  acids 87-143) were cloned into  the 
BamHI  site of pGEX-PT. pGEX-derived constructs  expressing GST fu- 
sion proteins  containing the  SH3 domains of  Yes, Crk, Abl, and phos- 
pholipase Cy were obtained from M. Sudol (Rockefeller University), M. 
Matsuda (NIH, Tokyo, Japan), A. M. Pendergast (Duke  University), and 
S. Earp (University of North Carolina), respectively. Fusion proteins 
were prepared as described previously (26). Microtiter wells were 
coated with 5-20 pg of GST-SH3 fusion  protein in PBS; blocked with 
100 mM Na,HCO,, 1% bovine serum albumin; and washed with five 
applications of PBS, 0.1% Tween 20,0.1% bovine serum  albumin (Buffer 
A). The  amount of protein bound to each well was  quantified by anti- 
GST antibody-based ELISA (Pharmacia Biotech Inc.) or with a GST- 
binding ~ e p t i d e . ~  
Isolation and Characterization of Src SH3-binding Phage-Library 
screens were performed as described previously (20). Briefly, 5 x 10" 
plaque-forming units of T9 (201,  T12: or T134 library  in Buffer A  were 
incubated in GST-Src SH3-coated wells for 2 h.  The wells were  washed 
five times with buffer A, and bound phage were eluted with 50 mM 
glycine-HC1 (pH 2.2). Recovered phage were amplified in DH5aF' 
Escherichia coli and affinity-purified twice more, as above. Binding 
phage  were  plated  to yield isolated  plaques, from which  phage  stocks 
and DNA were produced for binding experiments  and dideoxy sequenc- 
ing (27), respectively. Binding was confirmed by applying equal 
amounts of phage  to wells coated with GST-Src SH3  or GST, washing 
the wells with Buffer A, and detecting bound phage by anti-phage 
antibody-based ELISA (Pharmacia Biotech Inc.). 
In Vitro Peptide Binding Assays-Biotinylated peptides (Research 
Genetics, Birmingham, AL; Chiron Mimotopes, Victoria, Australia; 
Cytogen Corp., Princeton, NJ) were  synthesized with a GSGS peptide 
linker between the biotin moiety and  the NH, terminus of the indicated 
sequence. Peptide  purity  was assessed by high  pressure liquid chroma- 
tography andor  mass spectrometry. Binding experiments were per- 
formed as above, except for the use of 1 PM peptide instead of phage. 
Bound peptide  was  detected by streptavidin-alkaline phosphatase- 
based ELISA (Sigma). 
Peptide Competition of GSTSH3 Affinity Precipitations of Cell 
Lysates-NIH 3T3 cells were  labeled  overnight in Dulbecco's modified 
minimal medium, 10% dialyzed fetal calf serum, 80 pCi/ml Tran3'S- 
label  (ICN,  Irvine, CA). Labeled cells were washed with PBS, lysed in 
RIPA buffer, and clarified as described (28).  Lysate from 1.5 x lo6 cells 
was  incubated with  10  pg of glutathione-agarose-immobilized GST-SH3 
fusion protein  peptide in a final volume of 250 1.1. Pelleted  beads were 
washed with 1 ml each of RIP4  RIPA, 1% deoxycholate, 0.1% SDS; and 
PBS, then resuspended in SDS-polyacrylamide gel electrophoresis 
sample buffer, boiled, and subjected  to SDS-polyacrylamide gel electro- 
phoresis (7.5%). Labeled proteins were  detected with a PhosphorImager 
(Molecular Dynamics, Sunnyvale, CA). 
Progesterone-induced Oocyte Maturation-Stage VI oocytes were  pre- 
pared  and injected as described previously (29). Oocytes were injected 
with 40 nl of 100 p peptide, 1 mg/ml monoclonal antibody 327, or 
water. After injection, oocytes were  incubated in 2 pg/ml progesterone 
(Sigma) and were scored at hourly time points for germinal vesicle 
breakdown. 
RESULTS AND DISCUSSION 
In  an effort to  identify  peptide ligands for the  Src  SH3 do- 
main, we undertook the screening of three different phage- 
displayed  peptide libraries. Two of the  libraries, T9 and T12, 
each contain 2 x lo8 unique clones expressing 22- or 36-amino 
acid-long random peptides, respectively, fused to the amino 
terminus of M13 protein 111. As such,  they  represent a vast 
source of molecular  diversity and  have  the  potential  to encode 
A. B. Sparks  and B. K. Kay, unpublished  observations. 




T9.6 SSRGEGNNIISSRPFLSNSDPWSNKLTGRW GPLPPLP NDSRPSR 
T12.6 STAPWGLRVAHEGQYU-lELZIPP V W P S R  
T12.4 STNvwvTGSVIARQAQS RPLPIPP  ETRPSR 
T9.5 
T12.3 STNDVDWMHMWNSQGPH RRLPPTP  ATRPSR 








SSFDQQDWDYSIAEKMHPIRPQF RELPPLP  PSRASFGGGASRPSR 
SSSGYVVPKRLGDMREYNAHPQLHVPPN SPLPPLP  THLQSSRPSR 
SSDNWARRVHASELIYTDLSPQILLAQ RQLPPTP  GRDPSHSRPSR 
STRWSHSWPGYVGQANPSPAT R P L P W P  SR 
STAHSLWDWGTFSQVSHK SRLPPLP  TRPSR 
PQYARIVSYRF RALPSPP  SASRPSR 
SSESPLMYNRVGALQSLTSVQSMMHFALQ RRLPRTP  PPASRPSR 
STAVSFRFMPGGGEAFYST RPVPPIT  RPSR 





T13.7 STS  RPLPSLP  TTRP 
T13.3 STN  RPLPMIP  TTRP 
T13.10 STP  RPLPLIP  TTRP 
T13.8 
T13.2 
ST  RPLPPTP  LTTRP 
T13.9 ST  RPQPPPP  ITTRP 
ST  RSLPPLP  PTTRP 
T13.4 ST  RQLPIPP  TTTRP 
ST  RPLPILP  RTTRP 
ST  RPLPSLP  ITTRP 
Consensus RPLPPLP 
FIG. 1. Deduced amino acid  sequence of peptides  displayed  by 
Src SH3-selected  phage. A,  sequence of peptides  isolated from T9 and 
biased peptide library. Residues within  the peptides that  match  the 
T12 random  peptide  libraries. B,  sequence of peptides  isolated from T13 
consensus have been aligned. Bold residues are fixed in all library 
clones; sequences  included in  synthetic peptides are underlined. 
virtually every possible 7-amino acid-long peptide. The  third 
library, T13, contains approximately 1 x lo6 unique members 
expressing 8-amino acid-long peptides encoded by the DNA 
sequence ((C/A)NN),. This encoding  scheme results  in a biased 
peptide library  wherein  the  constituent amino  acids are  repre- 
sented in the following proportions: 6R:4P:4L:4T31:2H:2Q:- 
2K2N:2S:lM.  Many of these  residues  have been  identified in 
naturally occurring  SH3-binding  sequences (13-17, 30). 
Phage clones expressing  SH3-binding  peptides were affinity- 
purified  with immobilized GST-Src SH3 fusion protein. After 
three  rounds of purification,  isolated clones were confirmed as 
binding to Src  SH3  (data  not shown). Fig. 1 lists the amino acid 
sequences of peptides expressed on Src SH3-binding phage; 
similar sequences within  the peptides have been  aligned and 
yield a consensus motif of RPLPPLP. Peptides derived from 
screening  either  the  random peptide libraries (expressing all 20 
residues at each  position, Fig. IA) or the biased  peptide library 
(expressing 11 residues at each position, Fig. lB) yield the 
same consensus motif. These data  suggest that the sequence 
RPLPPLP  represents at least a significant part of the preferred 
Src SH3-binding motif. Support for this conclusion comes from 
a recent  study  in which a synthetic peptide library biased for 
SH3  ligands (of the formXXXPPXPXX) was used to identify Src 
SH3-binding peptides with  the consensus motif RXLPPLPR 
(31). Our identification of the  RPLPPLP motif from two random 
peptide libraries  with no a priori bias for any  particular se- 
quence characteristic,  together  with  the identification of the 
same motif from two different  biased  peptide libraries, provides 
strong evidence that the sequence RPLPPLP represents at 
least a significant part of the preferred Src SH3-binding motif. 
Biotinylated  peptides  corresponding to sequences  displayed 
by Src SH3-binding phage were  synthesized and  assayed for 
direct  binding  to immobilized GST-Src SH3 fusion protein (Fig. 
2A). Each of the library-derived  peptides bound GST-Src SH3 
over GST background.  This  binding was  not simply a conse- 
quence of the proline-rich nature of the library-derived pep- 
tides, since  a  proline-rich  peptide  from the cytoskeletal  protein 
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ficity of synthetic Src SH3-binding 
FIG. 2. Binding strength and speci- 
peptides. A, relative binding of peptides 
to GST-Src SH3. ELISA signal after 30 
min. E ,  relative binding of peptides to  var- 
ious GST-SH3 fusion proteins. ELISA sig- 
nal after 30 min (peptides pT13.5 and 
pLC) and after 240 min (all other pep- 
tides). Peptides (see Fig. 1 for library-de- 
rived sequences; other sequences are  as 
follows:  pVIN,  LAPPKPPLPEGEV;  pSOS, 
PPLP; pLC, STPRPLPPLPTTR)  were 
bound to equal amounts of immobilized 
GST-SH3 fusion protein. Bound  biotinyl- 
ated peptide was detected with streptavi- 
din-alkaline phosphatase ELISA. Each 
point was performed in triplicate; values 
are average absorbance at 405 nm  above 
bovine serum albumin background -r S.D. 
GTVEPVPPPVPPRRRPESA; PSC, RPL- 














vinculin (pVIN) exhibited no binding. Furthermore,  all  but one 
of the library-derived peptides bound Src SH3-GST better than 
did a previously characterized SH3-binding peptide from SOS 
(pSOS) (14). We observed a  strong correlation between the pep- 
tides’ similarity to the RPLPPLP motif and their affinity for Src 
SH3; experiments comparing the relative binding of various 
phage clones produced equivalent results (data not shown). 
Moreover, while none of the clones expressed the sequence 
RPLPPLP, a peptide (pLC) consisting of the RPLPPLP motif 
flanked by residues encoded by clone T13.5 bound Src SH3 
better than all other peptides tested. Taken together, these 
data provide further evidence that RPLPPLP represents at 
least  a significant part of the preferred Src SH3-binding motif. 
The single exception to the correlation between RPLPPLP 
similarity and Src SH3 binding, pT12.1,  bound  well despite its 
lack of similarity to the RPLPPLP motif (Fig. 2 A ) .  As pT12.1 
exhibits other unique characteristics (see below), it may repre- 
sent a distinct solution to Src SH3 binding. Interestingly, 
pT12.1 resembles SH3-binding sequences in SOS and  a set of 
Src SH3 ligands identified by Yu et al. (31) that did not match 
their consensus motif. 
Whereas pLC produced the strongest Src SH3-binding sig- 
nal,  a peptide consisting of the RPLPPLP motif alone (pSC) 
bound  poorly (Fig. 2 A ) .  Moreover, SH3-binding motifs tend to 
cluster near one end of the phage-displayed random peptides, 
adjacent to sequences that  are fured in every  clone (Fig. lA). 
This tendency has not been observed in binding populations 
selected with other proteins (20) and suggests that fixed flank- 
ing residues may facilitate SH3 binding by the phage. Thus, 
although RPLPPLP represents at least  a significant part of the 
preferred Src SH3-binding motif, sequences that flank RPLP- 
PLP may contribute to SH3 binding. This contribution may be 
an indirect consequence of increased stabilization of the RPLP- 
PLP binding conformation or a direct consequence of additional 
SH3-contact residues. The use of second generation random 
peptide libraries that fx all or part of the RPLPPLP motif and 
randomize flanking residues may help define additional resi- 
dues important for Src SH3 binding. 
To evaluate the specificities of the library-derived peptides, 
we determined their relative binding to SH3 domains from Src, 
Yes, Grb2, Crk, Abl, and phospholipase Cy (Fig. 2 B ) .  Of the 
peptides that demonstrated significant Src and Yes SH3 bind- 
ing, only  pT12.1 and pSOS  bound appreciably to SH3 domains 
from Grb2, Crk, and phospholipase Cy. Thus, peptides related 
to  the RPLPPLP consensus motif exhibit specificity  for the Src 
SH3 domain (and  the highly similar Yes SH3 domain), whereas 
the more divergent peptides pT12.1 and pSOS recognize a 
broad range of SH3 domains. That none of the peptides recog- 
nize Ab1 SH3 is consistent with the fact that they do not con- 
form to a previously  defined Ab1 SH3 consensus motif (13) and 
provides further evidence that SH3 domains possess distinct 
ligand specificities. 
GST-SH3  fusion proteins may be used to affinity precipitate 
SH3-binding proteins from  cell lysates. We therefore tested the 
ability of library-derived peptides to compete with cellular pro- 
teins for binding to the Src SH3 domain. As shown in Fig. 3, 
recovery of SH3-binding proteins with GST-Src SH3 could  be 
blocked in  a dose-dependent fashion (IC5o = 1 to 5 by Phos- 
phorImager densitometry) by pT12.1, pT12.6, and pLC, al- 
though 100 1” pVIN had no effect. Similar results were ob- 
tained  in experiments using GST-Yes SH3 (data not shown). 
This competition was specific for Src SH3, since  none of the 
peptides blocked association with Ab1 SH3, and only pT12.1 
significantly blocked binding to phospholipase Cy SH3. These 
results  are consistent with binding data presented in Fig. 2. 
Thus, the RPLPPLP-related peptides are able to specifically 
compete Src SH3 interactions with natural SH3-binding pro- 
teins in vitro, suggesting their potential for disrupting SH3- 
mediated events in vivo. 
X.  Zaevis oocytes injected with mRNA encoding constitutively 
active Src undergo progesterone-induced maturation at  an ac- 
celerated rate relative to oocytes injected with water or c-Src 
mRNA(32). Since the Src SH3 domain is thought to be  involved 
in the negative regulation of Src kinase and transforming ac- 
tivity (6-ll), we have examined the effect of Src SH3-binding 
peptides upon oocyte maturation. Fig. 4 shows that maturation 
was accelerated by approximately 1 h  in oocytes injected with 
pT12.6 or pLC, but not in oocytes injected with water, pVIN, 
the Src SH3-specific  monoclonal antibody 327, or pT12.1. The 
magnitude of this effect is similar to that seen with injection of 
mRNA encoding constitutively active Src (32). Interestingly, 
only RPLPPLP-related peptides with specificity for Src SH3 
were competent to  accelerate maturation. Although the pep- 
tides may be exerting their effect via a  target other than  the Src 
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FIG. 3. Peptide competition of Src SH3-GST precipitation of 
proteins from cell lysates. "S-Labeled NIH 3T3 cell lysates were 
incubated  with 1 pv glutathione-agarose-coupled GST-SH3 fusion pro- 
tein % peptide.  Final  peptide  concentrations  were 1, 10, and 100 pw for 











FIG. 4. Peptide acceleration of progesterone-induced oocyte 
maturation. Stage VI oocytes were  injected  with  peptide, monoclonal 
antibody 327, or injection buffer. For  each  treatment, 100 oocytes were 
injected, treated with progesterone, and scored for germinal vesicle 
breakdown (GVBD) a t  hourly  time  points.  Results are expressed as  a 
percentage of oocytes that  underwent  germinal vesicle breakdown by 
the indicated  time. 
SH3 domain, these results suggest the possibility that the 
RPLPPLP-related  peptides  are  able  to  antagonize  the negative 
regulation of Src activity by Src  SH3 in uiuo. Future  studies 
examining  the effect of these  peptides upon Src  kinase activity, 
substrate phosphorylation, and protein-protein interactions 
may clarify the specific mechanism  whereby the  peptides  exert 
their effect and may contribute  to  our  understanding of the role 
of the  Src  SH3 domain in uiuo. 
We have used  phage-displayed  peptide libraries  to identify 
the  Src SH3-binding motif RPLPPLP. Because this motif was 
identified from libraries with no a priori bias for any specific 
sequence characteristics, we conclude that RPLPPLP repre- 
sents a t  least a  significant part of the preferred Src SH3-bind- 
ing  sequence. Second generation biased libraries may provide a 
means of extending  the  Src SH3-binding motif, as well as  ad- 
dressing  the binding specificities of other  SH3 domains.  The 
isolation of biologically active Src  SH3  ligands from libraries 
incorporating no information regarding natural SH3-binding 
sequences suggests  that non-biased  peptide libraries may rep- 
resent a general and efficient means of discovering peptide 
ligands for, and characterizing binding specificities of, other 
domains  thought to be involved in protein-protein  interactions, 
such as  pleckstrin homology domains (33) and armadillo re- 
peats (25), even when no information is available regarding 
their  natural ligands. 
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